Key statistics
On Tuesday, Orchestra Biomed Holdings Inc (OBIO:NMQ) closed at 4.36, -19.62% below its 52-week high of 5.42, set on Nov 26, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 4.21 |
|---|---|
| High | 4.55 |
| Low | 4.21 |
| Bid | 4.35 |
| Offer | 4.91 |
| Previous close | 4.38 |
| Average volume | 283.25k |
|---|---|
| Shares outstanding | 56.46m |
| Free float | 34.43m |
| P/E (TTM) | -- |
| Market cap | 246.19m USD |
| EPS (TTM) | -1.82 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
More ▼
- Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
- Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
- Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
- Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting
- Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
- Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
- Orchestra BioMed to Host Business Update Call on November 12, 2025
- Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements
More ▼
